These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34814150)

  • 21. The diagnostic role of arginine-stimulated copeptin in the differential diagnosis of polyuria-polydipsia syndrome (PPS) in pediatric age.
    Tuli G; Munarin J; De Sanctis L
    Endocrine; 2024 May; 84(2):677-682. PubMed ID: 38155322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EJE AWARD 2019: New diagnostic approaches for patients with polyuria polydipsia syndrome.
    Christ-Crain M
    Eur J Endocrinol; 2019 Jul; 181(1):R11-R21. PubMed ID: 31067508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic Utility of Copeptin in Pediatric Patients with Polyuria-Polydipsia Syndrome: A Systematic Review and Meta-Analysis.
    Ciortea DA; Petrea Cliveți CL; Bujoreanu Bezman L; Vivisenco IC; Berbece SI; Gurău G; Matei MN; Nechita A
    Int J Mol Sci; 2024 Oct; 25(19):. PubMed ID: 39409072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in copeptin and bioactive vasopressin in runners with and without hyponatremia.
    Hew-Butler T; Hoffman MD; Stuempfle KJ; Rogers IR; Morgenthaler NG; Verbalis JG
    Clin J Sport Med; 2011 May; 21(3):211-7. PubMed ID: 21519298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validity of different copeptin assays in the differential diagnosis of the polyuria-polydipsia syndrome.
    Sailer CO; Refardt J; Blum CA; Schnyder I; Molina-Tijeras JA; Fenske W; Christ-Crain M
    Sci Rep; 2021 May; 11(1):10104. PubMed ID: 33980941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical settings and vasopressin function in hyponatraemic children.
    Gerigk M; Bald M; Feth F; Rascher W
    Eur J Pediatr; 1993 Apr; 152(4):301-5. PubMed ID: 8482276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A copeptin-based classification of the osmoregulatory defects in the syndrome of inappropriate antidiuresis.
    Fenske W; Sandner B; Christ-Crain M
    Best Pract Res Clin Endocrinol Metab; 2016 Mar; 30(2):219-33. PubMed ID: 27156760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Copeptin in the differential diagnosis of hypotonic polyuria.
    Christ-Crain M; Fenske WK
    J Endocrinol Invest; 2020 Jan; 43(1):21-30. PubMed ID: 31368050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arginine-stimulated copeptin in children and adolescents.
    Binder G; Weber K; Peter A; Schweizer R
    Clin Endocrinol (Oxf); 2023 Apr; 98(4):548-553. PubMed ID: 36710502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Arginine-stimulated copeptin measurements in the differential diagnosis of diabetes insipidus: a prospective diagnostic study.
    Winzeler B; Cesana-Nigro N; Refardt J; Vogt DR; Imber C; Morin B; Popovic M; Steinmetz M; Sailer CO; Szinnai G; Chifu I; Fassnacht M; Christ-Crain M
    Lancet; 2019 Aug; 394(10198):587-595. PubMed ID: 31303316
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined Arginine and Insulin Stimulation Elicits a Robust and Consistent Copeptin Response in Short Children.
    March CA; Sastry S; McPhaul MJ; Wheeler SE; Garibaldi L
    Horm Res Paediatr; 2023; 96(4):395-403. PubMed ID: 36513057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Very elevated serum copeptin concentrations occur in a subset of healthy children in the minutes after phlebotomy.
    Sastry S; March CA; McPhaul MJ; Garibaldi LR
    J Pediatr Endocrinol Metab; 2024 Jan; 37(1):8-14. PubMed ID: 37991411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Copeptin-based diagnosis of diabetes insipidus.
    Refardt J; Christ-Crain M
    Swiss Med Wkly; 2020 May; 150():w20237. PubMed ID: 32374887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biological Variation Estimates for Plasma Copeptin and Clinical Implications.
    Choy KW; Carobene A; Loh TP; Chiang C; Wijeratne N; Locatelli M; Coskun A; Cavusoglu C; Unsal I
    J Appl Lab Med; 2024 May; 9(3):430-439. PubMed ID: 38576222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Copeptin analysis in endocrine disorders.
    Moodley N
    Front Endocrinol (Lausanne); 2023; 14():1230045. PubMed ID: 37859988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transient severe hypotonic hyponatraemia in children - presentation of three cases.
    A Chrzanowska J; Wodniakowska J; Basiak A; Zubkiewicz-Kucharska A; Śmigiel R
    Pediatr Endocrinol Diabetes Metab; 2024; 30(2):97-103. PubMed ID: 39026487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Approach to the Patient: "Utility of the Copeptin Assay".
    Christ-Crain M; Refardt J; Winzeler B
    J Clin Endocrinol Metab; 2022 May; 107(6):1727-1738. PubMed ID: 35137148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Copeptin: diagnostic parameter, biomarker, or both?].
    Rutishauser J
    Ther Umsch; 2009 Nov; 66(11):731-4. PubMed ID: 19885789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of copeptin, a surrogate marker of arginine vasopressin, with cerebral vasospasm and delayed ischemic neurologic deficit after aneurysmal subarachnoid hemorrhage.
    Fernandez SJ; Barakat I; Ziogas J; Frugier T; Stylli SS; Laidlaw JD; Kaye AH; Adamides AA
    J Neurosurg; 2018 May; 130(5):1446-1452. PubMed ID: 29726784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diabetes insipidus.
    Christ-Crain M; Gaisl O
    Presse Med; 2021 Dec; 50(4):104093. PubMed ID: 34718110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.